Symbol="CNSP"
AssetType="Common Stock"
Name="Cns Pharmaceuticals Inc"
Description="CNS Pharmaceuticals, Inc., a clinical pharmaceutical company, is dedicated to the development of cancer drug candidates for the treatment of brain and central nervous system tumors. The company is headquartered in Houston, Texas."
CIK="1729427"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="2100 WEST LOOP SOUTH, SUITE 900, HOUSTON, TX, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="8928800"
EBITDA="-17034746"
PERatio="None"
PEGRatio="None"
BookValue="1.568"
DividendPerShare="0"
DividendYield="0"
EPS="-11.32"
RevenuePerShareTTM="0"
ProfitMargin="0"
OperatingMarginTTM="0"
ReturnOnAssetsTTM="-0.915"
ReturnOnEquityTTM="-1.864"
RevenueTTM="0"
GrossProfitTTM="0"
DilutedEPSTTM="-11.32"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0"
AnalystTargetPrice="10"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="-"
PriceToBookRatio="0.401"
EVToRevenue="-"
EVToEBITDA="0.289"
Beta="1.21"
num_52WeekHigh="8.64"
num_52WeekLow="0.611"
num_50DayMovingAverage="2.11"
num_200DayMovingAverage="2.616"
SharesOutstanding="4143300"
DividendDate="None"
ExDividendDate="None"
symbol="CNSP"
open="2.04"
high="2.16"
low="2.00"
price="2.15"
volume="91626.00"
latest_trading_day="2023-07-28"
previous_close="2.06"
change="0.09"
change_percent="4.1262%"
aroon_positive_momentum_days="69"
aroon_negative_momentum_days="0"
trend_strength="Absent or Weak Trend"
buying_signal="High Volatility / Hold Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="69"
Volume_recent_avg="2308096"
Change_recent_avg="0.01"
Delta_recent_avg="0.29"
Variance_recent_avg="0.14"
Change_ratio_recent_avg="-1.22"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="positive"
Aroon_change="FALSE"
Aroon_momentum_positive="69"
Aroon_momentum_negative="31"
image_negative_thumbnail_id_1="161"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0015.jpeg"
image_negative_thumbnail_id_2="109"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0067.jpeg"
image_neutral_thumbnail_id_1="590"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0009.jpeg"
image_neutral_thumbnail_id_2="550"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0049.jpeg"
image_positive_thumbnail_id_1="678"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0030.jpeg"
image_positive_thumbnail_id_2="669"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0039.jpeg"
image_professor_thumbnail_id_1="1180"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0014.jpeg"
image_professor_thumbnail_id_2="1195"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0029.jpeg"
